Locations
Cambridge, MA, USA · Cambridge, MA, USA · Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2018
Verve Therapeutics is a genetic medicines company focused on developing single-course gene editing therapies to address cardiovascular disease (CVD), the leading cause of death globally. Founded in 2018 by experts in cardiology and gene editing, Verve aims to disrupt the chronic care model for treating atherosclerotic cardiovascular disease (ASCVD) by targeting the root causes of the condition. Their pipeline includes innovative programs like VERVE-101, which targets the PCSK9 gene to lower LDL cholesterol levels. With a commitment to transforming patient care, Verve is well-positioned to make a significant impact in the field of cardiovascular health.
Something looks off?On-site & Remote